Similar Articles
481 Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
482 Surveillance for hepatocellular carcinoma at the community level: Easier said than done
483 Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
484 Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
485 Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
486 Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
487 Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
488 Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
489 Characterization of metabolic landscape in hepatocellular carcinoma
490 Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA